Belvedere Trading LLC Seres Therapeutics, Inc. Transaction History

Belvedere Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$2.33 - $5.07 $1,099 - $2,393	472 New	472 $1,000
Q3 2021 Oct 19, 2021	SELL	$5.46 - $22.6 $128,484 - $531,823	-23,532 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$18.46 - $24.36 $434,400 - $573,239	23,532 New	23,532 $488,000
Q1 2021 Apr 27, 2021	SELL	$17.66 - $28.92 $343,857 - $563,101	-19,471 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$23.25 - $37.73 $142,824 - $231,775	6,143 Added 46.09%	19,471 $477,000
Q3 2020 Nov 02, 2020	BUY	$3.74 - $28.74 $49,846 - $383,046	13,328 New	13,328 $377,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.